MNOV
MediciNova IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$69.89M
P/E Ratio
—
EPS
$-0.24
Beta
0.61
52W High
$1.96
52W Low
$1.17
50-Day MA
$1.51
200-Day MA
$1.39
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
8.53
PEG Ratio
-0.94
About MediciNova Inc
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapies for the treatment of serious diseases with unmet medical needs in the United States. The company is headquartered in La Jolla, California.
Fundamentals
| Revenue (TTM) | 409,660 |
| Gross Profit (TTM) | 31,050 |
| EBITDA | $-13.26M |
| Operating Margin | -2038.00% |
| Return on Equity | -25.50% |
| Return on Assets | -16.40% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.84 |
| Price-to-Book | 1.70 |
| Price-to-Sales (TTM) | 170.62 |
| EV/Revenue | 98.29 |
| EV/EBITDA | -2.65 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $49.22M |
| Float | $42.26M |
| % Insiders | 2.88% |
| % Institutions | 21.92% |
Analyst Ratings
Consensus ($9.00 target)
2
BuyData last updated: 4/8/2026